SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases

The purpose of this study is to prospectively evaluate the feasibility of SBRT for the management of synchronous oligo metastatic liver metastases from colorectal cancers.

Trial Details

NCT ID
NCT05775146
Phase
PHASE2
Sponsor
AHS Cancer Control Alberta
Status
RECRUITING
Cancer Type
Liver Cancer
Interventions
  • stereotactic body radiation treatment (SBRT)
Locations (sample)
  • Edmonton, Alberta, Canada|53.55014,-113.46871

Key Eligibility Criteria

  • Age ≥ 18 years
  • ECOG (Eastern Cooperative Oncology Group) 0-2
  • Able to provide written informed consent
  • 1-5 Liver lesions with max size of ≤5cm for a single lesion and restricted to one lobe of liver; deemed at Multi-Disciplinary Tumor Board (MDT) to …

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Liver Cancer Trials on Trialify →